Myriad Genetics Inc (MYGN)

R&D to Revenue

13.11%

Quarterly · Period ending:

MYGN logo

MYGN R&D to Revenue

Latest reported13.11%
MYGN Quarterly R&D/Revenue (0.00% → 13.11%)
High-resolution chart · PNG

MYGN r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
13.1096%
13.523%
12.1544%
13.7093%
12.0131%
14.0378%
15.2896%
13.3615%
12.8132%
12.3145%
10.6816%
12.5065%
11.5531%
12.4172%
13.1609%
13.1074%
11.3218%
12.8563%
12.7488%
11.2373%
10.2957%
13.3449%
0%
12.1212%
18.6695%
12.0122%
9.6361%
11.4332%
9.7029%
9.9261%
10.3321%
10.4301%
9.0816%
10.1038%
8.9409%
9.9553%
9.3766%
8.9385%
9.4656%
10.9296%
10.4614%
9.0289%
8.6394%
9.3733%
9.8481%
9.2628%
9.4924%
13.3957%
10.6942%
7.3238%
8.375%
8.2991%
8.3744%
8.7032%
9.4589%
8.5434%
9.1332%
9.0563%
8.3405%
7.7002%
8.594%
6.5124%
6.0653%
6.2727%
5.5926%
6.4791%
5.4534%
6.6681%
-45.7156%
20.6284%
23.766%
23.2845%
33.0974%
50.4509%
48.1231%
53.9199%
57.5553%
57.1589%
66.6864%
78.5618%
75.8595%
73.6925%
69.6304%
73.5287%
61.4079%
77.8518%
74.0669%
78.5877%
79.6444%
90.0698%
81.6935%
94.8947%
85.1503%
68.7034%
71.7904%
70.5693%
75.6847%
66.9301%
63.9117%
62.6335%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.